Top Suppliers:I want be here


4105-38-8

4105-38-8 structure
4105-38-8 structure
  • Name: uridine triacetate
  • Chemical Name: 2',3',5'-Tri-O-acetyluridine
  • CAS Number: 4105-38-8
  • Molecular Formula: C15H18N2O9
  • Molecular Weight: 370.311
  • Catalog: Biochemical Nucleoside drugs Nucleoside intermediate
  • Create Date: 2018-09-16 10:49:26
  • Modify Date: 2026-07-06 20:55:31
  • Uridine triacetate (Tri-O-acetyl uridine) is an orally active prodrug of Uridine. Uridine triacetate (Tri-O-acetyl uridine) is lipophilic, is quickly absorbed in the gut, and is rapidly deacetylated in the circulation to yield free uridine. Uridine triacetate (Tri-O-acetyl uridine) is uesd for the prevention and treatment of life-threatening 5-fluorouracil and capecitabine toxicity. Uridine triacetate (Tri-O-acetyl uridine) delivers high concentrations of uridine, which competes with toxic 5-FU metabolites[1][2].

Name 2',3',5'-Tri-O-acetyluridine
Synonyms 1-((2R,3R,4R,5R)-3,4-Diacetyl-3,4-dihydroxy-5-(1-hydroxy-2-oxopropyl)tetrahydrofuran-2-yl)pyriMidine-2,4(1H,3H)-dione
Vistogard
TAU
Tri-O-acetyl uridine
Mtapt
UNII-2WP61F175M
(2R,3R,4R,5R)-2-(Acetoxymethyl)-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)tetrahydrofuran-3,4
2`,3`,5`-Triacetyluridine
URIDINE 2',3',5'-TRIACETATE
EINECS 223-881-5
Uridine 2',3',5'-triacetate
2',3',5'-Tri-O-acetyluridine //BP
2’,3’,5’-Triacetyluridine
2`,3`,5`-Tracetyluridine
ANTI-TAU (MAPT) (S720) antibody produced in rabbit
2',3',5'-Tri-O-acety
DDPAC
2',3',5'-Tri0acetyluridine
1-(2-O,3-O,5-O-Triacetyl-β-D-ribofuranosyl)-4-hydroxypyrimidine-2(1H)-one
2',3',5'-Triacetyluridine
Phospho-14-&theta
[4-acetyloxy-2-(acetyloxymethyl)-5-(2,4-dioxopyrimidin-1-yl)oxolan-3-yl] acetate
Xuriden
[(2S,3R,4S,5S)-3,4-bis(acetyloxy)-5-(2,4-dioxo-1,2,3,4-tetrahydropyriMidin-1-yl)oxolan-2-yl]Methyl acetate
2',3',5'-trioacetyluridine
MFCD00023795
Vistonuridine
2-[(acetyloxy)methyl]-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)tetrahydrofuran-3,4-diyl diacetate
1-((2R,3R,4R,5R)-3,4-Diacetyl-3,4-dihydroxy-5-(1-hydroxy-2-oxopropyl)tetrahydrofuran-2-yl)pyri
2',3',5-TRI-ACETYLURIDINE
2',3',5'-Tri-O-acetyl-D-uridine
Mouse Anti-Tau antibody
2',3',5'-Tri-O-acetyl-rU
[4-acetyloxy-2-(acetyloxymethyl)-5-(
Uridine, 2',3',5'-triacetate
(2R,3R,4R,5R)-2-(AcetoxyMethyl)-5-(2,4-dioxo-3,4-dihydropyriMidin-1(2H)-yl)tetrahydrofuran-3,4-diyl diacetate
2',3',5'-tri-O-Acetyluridine (HPLC)
Microtubule-associated protein tau
(2R,3R,4R,5R)-2-(Acetoxymethyl)-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)tetrahydrofuran-3,4-diyl diacetate
Uridine triacetate, 10 mM in DMSO
acetic acid [4-acetoxy-2-(acetoxymethyl)-5-(2,4-diketopyrimidin-1-yl)tetrahydrofuran-3-yl] ester
FTDP-17
(Ser232) BioAssay&trade
acetic acid [4-acetoxy-2-(acetoxymethyl)-5-(2,4-dioxo-1-pyrimidinyl)-3-tetrahydrofuranyl] ester
2'', 3'', 5''-TRIACETYLURIDINE (2'', 3'', 5''-TRI-O-ACETYLURIDINE)
1-((2R,3R,4R,5R)-3,4-Diacetyl-3,4-dihydroxy-5-(1-hydroxy-2-oxopropyl)tetrahydrofuran-2-yl)pyrimid
[(2R,3R,4R,5R)-4-acetyloxy-2-(acetyloxymethyl)-5-(2,4-dioxopyrimidin-1-yl)oxolan-3-yl] ethanoate
phosphorylated (S232)
ANTI-TAU(C-TERMINAL) antibody produced in rabbit
[4-acetoxy-2-(acetoxymethyl)-5-(2,4-dioxopyrimidin-1-yl)tetrahydrofuran-3-yl] acetate
MAPTL
PPP1R103
2-(acetoxymethyl)-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)tetrahydrofuran-3,4-diyl diacetate
Uridine triacetate
acetic acid [(2R,3R,4R,5R)-4-acetoxy-2-(acetoxymethyl)-5-(2,4-diketopyrimidin-1-yl)tetrahydrofuran-3-yl] ester
O2',O3',O5'-triacetyl-uridine
2',3',5'-TriacetyL
MTBT1
2',3',5'-O-triacetyluridine
MTBT2
[(2R,3R,4R,5R)-4-acetyloxy-2-(acetyloxymethyl)-5-(2,4-dioxopyrimidin-1-yl)oxolan-3-yl] acetate
Description Uridine triacetate (Tri-O-acetyl uridine) is an orally active prodrug of Uridine. Uridine triacetate (Tri-O-acetyl uridine) is lipophilic, is quickly absorbed in the gut, and is rapidly deacetylated in the circulation to yield free uridine. Uridine triacetate (Tri-O-acetyl uridine) is uesd for the prevention and treatment of life-threatening 5-fluorouracil and capecitabine toxicity. Uridine triacetate (Tri-O-acetyl uridine) delivers high concentrations of uridine, which competes with toxic 5-FU metabolites[1][2].
Related Catalog
References

[1]. Ma WW, et al. Emergency use of uridine triacetate for the prevention and treatment of life-threatening 5-fluorouracil and capecitabine toxicity. Cancer. 2017 Jan 1;123(2):345-356.

[2]. Cada DJ, et al. Uridine Triacetate. Hosp Pharm. 2016 Jun;51(6):484-8.

Density 1.4±0.1 g/cm3
Melting Point 124-134ºC
Molecular Formula C15H18N2O9
Molecular Weight 370.311
Exact Mass 370.101227
PSA 142.99000
LogP -0.11
Index of Refraction 1.552
Storage condition −20°C
Personal Protective Equipment Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter
Hazard Codes Xi
RIDADR NONH for all modes of transport
WGK Germany 3
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.